| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
218,697 |
206,826 |
$28.82M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
26,001 |
25,885 |
$22.72M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
231,814 |
215,767 |
$19.97M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
593,191 |
536,134 |
$17.88M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
582,904 |
528,147 |
$16.85M |
| S4993 |
Contraceptive pills for birth control |
101,124 |
100,680 |
$13.77M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
48,115 |
46,408 |
$10.91M |
| S0199 |
Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs |
20,720 |
20,608 |
$9.97M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
33,782 |
33,610 |
$8.50M |
| J3490 |
Unclassified drugs |
216,627 |
187,018 |
$8.09M |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
9,454 |
9,407 |
$7.26M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
98,273 |
93,652 |
$6.50M |
| 11981 |
|
29,303 |
29,050 |
$6.12M |
| J7304 |
Contraceptive supply, hormone containing patch, each |
4,987 |
4,952 |
$5.51M |
| 87806 |
|
217,019 |
187,639 |
$5.15M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
39,828 |
38,343 |
$5.14M |
| J7300 |
Intrauterine copper contraceptive (paragard) |
7,230 |
7,196 |
$5.09M |
| 58300 |
|
43,059 |
21,850 |
$3.98M |
| A4267 |
Contraceptive supply, condom, male, each |
434,195 |
421,760 |
$3.83M |
| 90651 |
|
13,278 |
13,202 |
$3.34M |
| 11976 |
|
55,667 |
28,436 |
$2.98M |
| 81025 |
|
586,932 |
556,663 |
$1.94M |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
24,033 |
22,118 |
$1.81M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
32,124 |
31,733 |
$1.39M |
| 59840 |
|
8,690 |
4,573 |
$1.39M |
| S0190 |
Mifepristone, oral, 200 mg |
19,836 |
19,712 |
$1.07M |
| 58301 |
|
31,402 |
15,895 |
$882K |
| 57454 |
|
13,495 |
6,819 |
$777K |
| J7303 |
Contraceptive supply, hormone containing vaginal ring, each |
3,858 |
3,821 |
$641K |
| 99000 |
|
172,524 |
168,639 |
$626K |
| S5000 |
Prescription drug, generic |
132,155 |
119,900 |
$614K |
| Q3014 |
Telehealth originating site facility fee |
28,243 |
25,626 |
$549K |
| Q0144 |
Azithromycin dihydrate, oral, capsules/powder, 1 gram |
33,852 |
29,258 |
$497K |
| 83986 |
|
151,403 |
131,043 |
$419K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
32,457 |
32,457 |
$413K |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
113,397 |
111,062 |
$399K |
| 99201 |
|
3,790 |
3,691 |
$351K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
4,443 |
4,414 |
$319K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
3,891 |
3,848 |
$295K |
| 90674 |
|
8,370 |
8,338 |
$250K |
| 59841 |
|
1,015 |
504 |
$238K |
| J7295 |
Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |
1,332 |
1,332 |
$197K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,448 |
639 |
$156K |
| 99243 |
|
2,411 |
2,391 |
$143K |
| 55250 |
|
888 |
448 |
$132K |
| 99401 |
|
6,843 |
6,827 |
$129K |
| 81002 |
|
43,528 |
42,592 |
$91K |
| S0191 |
Misoprostol, oral, 200 mcg |
19,294 |
18,964 |
$89K |
| 96156 |
|
1,207 |
1,203 |
$86K |
| 99385 |
|
397 |
396 |
$75K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14,211 |
14,001 |
$67K |
| 90834 |
Psychotherapy, 45 minutes with patient |
805 |
463 |
$62K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15,283 |
13,858 |
$60K |
| Z1034 |
|
1,061 |
1,020 |
$58K |
| 0011A |
|
1,423 |
1,416 |
$54K |
| 0012A |
|
1,039 |
1,029 |
$40K |
| 85018 |
|
12,037 |
11,427 |
$35K |
| 90746 |
|
550 |
548 |
$34K |
| S5001 |
Prescription drug, brand name |
14,650 |
14,384 |
$29K |
| 57460 |
|
260 |
130 |
$27K |
| 90715 |
|
592 |
585 |
$25K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
2,082 |
2,056 |
$23K |
| 99402 |
|
598 |
598 |
$19K |
| 0064A |
|
543 |
542 |
$18K |
| 56501 |
|
391 |
172 |
$18K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
2,166 |
1,748 |
$18K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
289 |
282 |
$17K |
| 76830 |
Ultrasound, transvaginal |
249 |
244 |
$17K |
| 86901 |
|
5,024 |
4,937 |
$15K |
| 87210 |
|
3,334 |
3,214 |
$15K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
254 |
250 |
$12K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
770 |
765 |
$12K |
| 59425 |
|
207 |
202 |
$11K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
283 |
283 |
$11K |
| 99442 |
|
2,373 |
2,270 |
$10K |
| 54056 |
|
247 |
113 |
$9K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,382 |
4,352 |
$9K |
| 99441 |
|
2,095 |
2,031 |
$8K |
| S0197 |
Prenatal vitamins, 30-day supply |
2,438 |
2,405 |
$4K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
403 |
399 |
$4K |
| 90707 |
|
42 |
42 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
833 |
820 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
366 |
359 |
$3K |
| 76857 |
|
55 |
41 |
$2K |
| 0001A |
|
52 |
52 |
$2K |
| 90832 |
Psychotherapy, 30 minutes with patient |
34 |
26 |
$2K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
76 |
76 |
$1K |
| 86580 |
|
73 |
66 |
$807.28 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
374 |
374 |
$733.70 |
| 96127 |
|
173 |
161 |
$544.30 |
| 99242 |
|
12 |
12 |
$470.12 |
| 76882 |
|
13 |
12 |
$294.63 |
| 3074F |
|
1,310 |
1,290 |
$0.00 |
| 2000F |
|
342 |
320 |
$0.00 |
| 1036F |
|
766 |
746 |
$0.00 |
| H0001 |
Alcohol and/or drug assessment |
91 |
91 |
$0.00 |
| 99443 |
|
42 |
38 |
$0.00 |
| 3008F |
|
53 |
53 |
$0.00 |
| 3079F |
|
12 |
12 |
$0.00 |
| 3078F |
|
1,215 |
1,197 |
$0.00 |
| 1160F |
|
1,074 |
1,051 |
$0.00 |
| 1159F |
|
1,075 |
1,053 |
$0.00 |
| 88147 |
|
627 |
619 |
$0.00 |
| 1158F |
|
52 |
52 |
$0.00 |